MU researchers find unique protein organization in arteries associated with cardiovascular disease

As people age, the level of elastin diminishes and other proteins, such as collagen, contribute to altering the arterial stiffness. The researchers believe that learning how to alter elastin levels may alleviate some of the detrimental results associated with vascular aging, such as high blood pressure.

"When people think of blood vessels, they tend to think of rigid pipes, but blood vessels are very dynamic because they continually expand and contract to adjust blood flow and blood pressure to meet the body's needs," said Michael Hill, also of the Dalton Cardiovascular Research Center and Professor of Medical Pharmacology and Physiology. "Elastin production peaks at a very young age and declines throughout life. Molecular biologists are trying to determine how to turn elastin production back on in the correct places, but it has proven very difficult so far."

The following movies show sequential stacks of images starting on the outer wall of each small artery and progressing into the lumen of the blood vessel. They are followed by a rotating 3-D reconstruction of the image stack. In all movies the red stained fibers on the outside of the skeletal muscle and abdominal vessels consist of the protein elastin. All vessels have an internal elastin sheet that separates cells lining the lumen of the blood vessels and the muscle cells in the wall. The green dye stains cell nuclei so the orientation of cells can be visualized.

(Photo Credit: MU News Bureau)

The MU researchers believe the knowledge also may be used in future efforts to develop artificial vascular structures to improve tissue replacement. Blood vessels sometimes fail during the tissue replacement process, and understanding how vessels are built and change could lead to a better success rate.

The study, "Spatial Distribution and Mechanical Function of Elastin in Resistance Arteries," was published in Arteriosclerosis, Thrombosis, and Vascular Biology, the Journal of the American Heart Association. The study was funded by the National Institutes of Health.

Gerald Meininger is the director of the MU Dalton Cardiovascular Research Center and Margaret Proctor Mulligan Professor of Medical Pharmacology and Physiology.

(Photo Credit: MU News Bureau)

Michael Hill from the Dalton Cardiovascular Research Center is a professor of medical pharmacology and physiology.

(Photo Credit: MU News Bureau)

Source: University of Missouri-Columbia